# Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)

> **NCT03561961** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 526 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **RADIATION:** Moderate Hypo-fractionation
- **RADIATION:** Extreme Hypo-fractionation

## Key facts

- **NCT ID:** NCT03561961
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-24
- **Primary completion:** 2024-09-27
- **Final completion:** 2035-03
- **Target enrollment:** 526 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561961, "Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03561961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*